Clinical Trial Update: Efficacy & Safety Study of VESIcare® (Solifenacin Succinate) in Patients Wishing to Switch From Detrol LA® for Treatment of Overactive Bladder [Phase 3]

View source ↗

Summary

Phase 3 efficacy and safety study evaluating solifenacin succinate (VESIcare) for patients wishing to switch from Detrol LA in overactive bladder has completed.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Vesicare (solifenacin succinate)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Urinary Bladder, Overactive | Phase 3 | Status: COMPLETED